Medical Coating Market - Global Forecast to 2030
商品番号 : SMB-82428
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 290 |
| 図表数 | 344 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートでは、医療用コーティング市場をコーティングの種類、材質、基材、用途、地域別に分析し、地域別の市場全体の推定値を示しています。主要業界プレーヤーを徹底的に分析し、医療用コーティング市場に関連する事業概要、製品・サービス、主要戦略、新製品の発売、事業拡大、合併・買収に関する洞察を提供しています。
The medical coating market is expected to reach USD 15,813.6 million by 2030, up from USD 9,983.0 million in 2025, growing at a CAGR of 9.6%. The rising demand for medical devices in the healthcare sector significantly drives the growth of the medical coating market, as coatings continue to evolve and become crucial for the safety, performance, and durability of devices. An aging population and a higher prevalence of chronic diseases create a greater need for coated devices such as implants, catheters, and surgical instruments, thereby supporting market growth and fostering innovation.
医療用コーティング市場は、2025年の99億8,300万米ドルから2030年には158億1,360万米ドルに達し、年平均成長率（CAGR）9.6%で成長すると予測されています。ヘルスケア分野における医療機器の需要増加は、コーティングが進化を続け、機器の安全性、性能、耐久性にとって不可欠な要素となっているため、医療用コーティング市場の成長を大きく牽引しています。高齢化と慢性疾患の罹患率の上昇は、インプラント、カテーテル、外科用器具などのコーティングされた機器の需要を高め、市場の成長を支え、イノベーションを促進します。
“Based on application, medical devices will be the largest application in the medical coating market during the forecast period, in terms of value.”
The medical devices application segment is projected to be the largest in the medical coating market by value during the forecast period due to the widespread and increasing use of coated devices across all organizations and healthcare settings. The adoption of various coated medical devices is mainly driven by the rising rates of chronic diseases, the growing aging global population, and advancements in minimally invasive surgical procedures, all of which require performance-enhanced, safer, and easier-to-use medical devices. Medical coatings are vital for many devices, including catheters, stents, guidewires, orthopedic implants, and surgical instruments, as they offer superior lubricity, biocompatibility, and antimicrobial properties. These coatings reduce friction, minimizing tissue trauma, lower infection risks, and improve device performance and shelf-life. Additionally, the rise in hospital-acquired infections has made antimicrobial and anti-thrombogenic coatings essential for patient safety and meeting strict regulatory standards. Innovations in medical technology, such as imaging systems and precision instruments, have significantly increased the demand for high-performance medical coatings to achieve more accurate and less traumatic surgical outcomes. Therefore, the medical devices segment is expected to continue its growth.
“Based on coating type, active coating will be the fastest in the medical coating market during the forecast period, in terms of value.”
Active coatings are the fastest-growing type of coating by value in the medical coating market during the forecast period, due to their specialized therapeutic capabilities compared to passive coatings and the increasing demand for innovative solutions to improve patient safety and clinical outcomes. While passive coatings only provide surface protection during use (such as protection and lubrication), active coatings are engineered to release drugs, antimicrobial agents, or bioactive molecules at the application site. This delivery method is essential for high-risk medical devices (like stents, catheters, and orthopedic implants) where infection, thrombosis, and inflammation threaten successful patient management. The rise in hospital-acquired infections and the worldwide increase in chronic diseases and comorbidities expose chronic patients to higher infection risks, as post-surgical complications—such as PMN-mediated inflammation and infections—lead to extended risks and costs. Therefore, hospitals and healthcare providers are seeking more effective coatings that reduce the risk of hospital-acquired infections and promote faster recovery.
“Based on region, North America accounts for the largest share in the medical coating market, in terms of value.”
North America is the largest and fastest-growing region in the medical coating market, with value growth driven by advanced healthcare delivery systems, an increase in procedures performed, and a strong commitment to the continuous development of medical devices. North America, especially the United States, hosts many top medical device manufacturers and research institutions that are innovating the next generation of coatings for applications such as cardiovascular stents, orthopedic implants, catheters, and surgical instruments. Additionally, the rising demand for medical coatings in North America is linked to a growing and aging population with increasing rates of chronic diseases, as well as a heightened focus on infection control and patient safety, which demand sophisticated, biocompatible, and antimicrobial coatings.
During the process of determining and verifying the market size for various segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees is as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: Directors- 35%, Managers – 25%, and Others – 40%
- By Region: North America – 22%, Europe – 22%, Asia Pacific – 45%, RoW – 11%
The key players in this market are Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US) and The Sherwin-Williams Company (US).
Research Coverage
This report breaks down the medical coating market by coating type, material, substrate, application, and region, and provides estimates for the total market value across different regions. A thorough analysis of major industry players has been carried out to offer insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions related to the medical coating market.
Key benefits of buying this report
This research report covers different levels of analysis, including industry examination (industry trends), market ranking analysis of leading players, and company profiles. Together, these provide a comprehensive view of the competitive landscape, emerging and high-growth segments of the medical coating market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following:
- Analysis of key drivers (increasing demand for minimally invasive surgical procedures, growing geriatric population and prevalence of chronic diseases), restraints (stringent regulatory requirements, high costs and technical challenges), opportunities (development of smart and multifunctional coatings, expansion in emerging markets) and challenges (technical limitations in coating durability and adhesion, intellectual property and supply chain issues).
- Market Penetration: Comprehensive information on the medical coating market offered by top players in the global medical coating market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical coating market
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical coating market across regions
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical coating market
- Competitive Assessment: In-depth assessment of market share, strategies, products, and manufacturing capabilities of leading players in the medical coating market
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS & EXCLUSIONS OF STUDY 27
1.4 CURRENCY CONSIDERED 27
1.5 UNITS CONSIDERED 27
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 30
2.1.1.1 List of key secondary sources 30
2.1.1.2 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Key data from primary sources 31
2.1.2.2 List of primary interview participants—demand and supply sides 31
2.1.2.3 Key industry insights 32
2.1.2.4 Breakdown of interviews with experts 32
2.2 MARKET SIZE ESTIMATION 32
2.2.1 BOTTOM-UP APPROACH 33
2.2.2 TOP-DOWN APPROACH 33
2.3 FORECAST NUMBER CALCULATION 34
2.4 DATA TRIANGULATION 35
2.5 FACTOR ANALYSIS 36
2.6 ASSUMPTIONS 36
2.7 LIMITATIONS & RISKS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 41
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL COATING MARKET 41
4.2 MEDICAL COATING MARKET, BY COATING TYPE 41
4.3 MEDICAL COATING MARKET, BY MATERIAL 42
4.4 MEDICAL COATING MARKET, BY SUBSTRATE 42
4.5 MEDICAL COATING MARKET, BY APPLICATION 43
4.6 MEDICAL COATING MARKET, BY KEY COUNTRY 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Increasing prevalence of chronic diseases and aging population 45
5.2.1.2 Rise in hospital-acquired infections 45
5.2.1.3 Growth in minimally invasive surgeries and medical device usage 45
5.2.2 RESTRAINTS 46
5.2.2.1 Low shelf life and durability issues 46
5.2.2.2 Raw material price volatility and high costs 46
5.2.2.3 Strict government regulations and compliance challenges 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Rise in demand for antimicrobial and drug-eluting coatings 47
5.2.3.2 Technological advancements and nanotechnology 47
5.2.4 CHALLENGES 48
5.2.4.1 Biocompatibility and durability concerns 48
5.2.4.2 Complex application and quality control 48
6 INDUSTRY TRENDS 49
6.1 VALUE CHAIN ANALYSIS 49
6.1.1 RAW MATERIAL SUPPLIERS 49
6.1.2 MANUFACTURERS 49
6.1.3 DISTRIBUTORS 50
6.1.4 END USERS 50
6.2 ECOSYSTEM ANALYSIS 50
6.3 PORTER’S FIVE FORCES ANALYSIS 51
6.3.1 THREAT OF NEW ENTRANTS 52
6.3.2 THREAT OF SUBSTITUTES 52
6.3.3 BARGAINING POWER OF SUPPLIERS 53
6.3.4 BARGAINING POWER OF BUYERS 53
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.4 KEY STAKEHOLDERS AND BUYING CRITERIA 54
6.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 54
6.4.2 QUALITY 54
6.4.3 SERVICE 54
6.4.4 BUYING CRITERIA 55
6.5 TRADE ANALYSIS 56
6.5.1 EXPORT SCENARIO (HS CODE 9018) 56
6.5.2 IMPORT SCENARIO (HS CODE 9018) 57
6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58
6.7 TECHNOLOGY ANALYSIS 59
6.7.1 KEY TECHNOLOGIES 59
6.7.1.1 Plasma spraying 59
6.7.1.2 Chemical vapor deposition 59
6.7.1.3 Microblasting & laser treatments 59
6.7.2 COMPLEMENTARY TECHNOLOGIES 60
6.7.2.1 Nanotechnology integration 60
6.7.2.2 Advanced material formulation 60
6.8 MACROECONOMIC INDICATORS 60
6.8.1 GDP TRENDS AND FORECASTS 60
6.9 PRICING ANALYSIS 62
6.9.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 62
6.9.2 AVERAGE SELLING PRICE TREND, BY COATING TYPE, 2022–2024 63
6.10 REGULATORY LANDSCAPE 64
6.10.1 NORTH AMERICA 64
6.10.2 ASIA PACIFIC 65
6.10.3 EUROPE 65
6.10.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND
OTHER ORGANIZATIONS 66
6.11 IMPACT OF AI/GEN AI 67
6.12 KEY CONFERENCES AND EVENTS, 2025–2026 68
6.13 CASE STUDY ANALYSIS 68
6.13.1 ANTIMICROBIAL COATING FOR IMPLANTABLE PACEMAKER DEVICE 68
6.13.2 INTRICOAT FOR MEDICAL ROBOTICS PROJECT 69
6.13.3 SLIPS COATING TO PREVENT BIOFILM FORMATION ON MEDICAL IMPLANTS 69
6.14 INVESTMENT AND FUNDING SCENARIO 70
6.15 PATENT ANALYSIS 70
6.15.1 INTRODUCTION 70
6.15.2 LEGAL STATUS OF PATENTS 72
6.15.3 JURISDICTION ANALYSIS 72
6.16 IMPACT OF 2025 US TARIFF – OVERVIEW 73
6.16.1 INTRODUCTION 73
6.17 KEY TARIFF RATES 73
6.18 PRICE IMPACT ANALYSIS 74
6.19 IMPACT ON COUNTRY/REGION 74
6.19.1 US 74
6.19.2 EUROPE 75
6.19.3 ASIA PACIFIC 76
6.20 IMPACT ON END-USE INDUSTRIES 77
7 MEDICAL COATINGS MARKET, BY COATING TYPE 78
7.1 INTRODUCTION 79
7.2 ACTIVE 81
7.2.1 ANTIMICROBIAL 81
7.2.1.1 Used to prevent microbial infection on medical devices 81
7.2.2 OTHERS 81
7.3 PASSIVE 82
7.3.1 HYDROPHILIC/LUBRICIOUS HYDROPHILIC 82
7.3.1.1 Growing awareness of minimally invasive surgical techniques to boost demand 82
7.3.2 HYDROPHOBIC 83
7.3.2.1 High water resistance to drive market growth 83
8 MEDICAL COATINGS MARKET, BY MATERIAL TYPE 84
8.1 INTRODUCTION 85
8.2 POLYMERS 88
8.2.1 FLUOROPOLYMERS 88
8.2.1.1 PTFE 88
8.2.1.1.1 Minimal friction and strong resistance to heat and chemicals to boost adoption 88
8.2.1.2 PVDF 89
8.2.1.2.1 Exceptionally robust and resistant to chemicals 89
8.2.1.3 Others 89
8.2.2 PARYLENE 89
8.2.2.1 Frictional coefficient comparable to PTFE – key segment driver 89
8.2.3 SILICONES 89
8.2.3.1 Biocompatibility fuels widespread adoption in medical applications 89
8.2.4 OTHERS 90
8.3 METALS 90
8.3.1 SILVER 90
8.3.1.1 Antimicrobial properties boost application 90
8.3.2 TITANIUM 91
8.3.2.1 Commonly employed in implant applications due to excellent biocompatibility 91
8.3.3 OTHERS 91
8.4 OTHERS 91
9 MEDICAL COATINGS MARKET, BY SUBSTRATE 92
9.1 INTRODUCTION 93
9.2 METALS 95
9.2.1 METALS IN IMPLANTED MEDICAL DEVICES: DRIVING BIOCOMPATIBILITY
AND MARKET GROWTH 95
9.3 CERAMICS 95
9.3.1 WIDELY USED IN DENTAL IMPLANT APPLICATIONS 95
9.4 POLYMERS 96
9.4.1 FLUOROPOLYMERS 96
9.4.1.1 PTFE’s unparalleled lubricity boosts advanced medical
device performance 96
9.4.2 SILICONE 96
9.4.2.1 Superior compatibility with human tissue and bodily fluids 96
9.4.3 OTHER POLYMERS 97
9.5 COMPOSITES 97
9.5.1 LIGHT WEIGHT PROPERTY ENHANCES PROSTHETIC MOBILITY 97
9.6 GLASS 97
9.6.1 OFFERS BIOCOMPATIBILITY FOR SAFE AND DURABLE MEDICAL IMPLANTS 97
10 MEDICAL COATINGS MARKET, BY APPLICATION 98
10.1 INTRODUCTION 99
10.2 MEDICAL DEVICES 102
10.2.1 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO BOOST MARKET 102
10.3 MEDICAL IMPLANTS 102
10.3.1 ORTHOPEDIC IMPLANTS 102
10.3.1.1 Lubricity and fatigue strength in orthopedic implants 102
10.3.2 DENTAL IMPLANTS 103
10.3.2.1 Use of hydroxyapatite in dental implants to stimulate bone healing 103
10.3.3 CARDIOVASCULAR IMPLANTS 103
10.3.3.1 Nanomaterial coatings used for stents 103
10.4 MEDICAL EQUIPMENT & TOOLS 103
10.4.1 SURGICAL EQUIPMENT & TOOLS 104
10.4.1.1 Antimicrobial and other functional properties benefit surgical tools 104
10.4.2 INSTITUTIONAL EQUIPMENT 104
10.4.2.1 Hydrophobic coatings – widely used in institutional equipment 104
10.5 PROTECTIVE CLOTHING 104
10.5.1 HELPS ENHANCE HEALTHCARE SAFETY 104
10.6 OTHERS 105
11 MEDICAL COATING MARKET, BY REGION 106
11.1 INTRODUCTION 107
11.2 NORTH AMERICA 109
11.2.1 US 117
11.2.1.1 Ongoing advancements in medical technology to propel market 117
11.2.2 CANADA 120
11.2.2.1 Rising investments to boost demand for medical coatings 120
11.2.3 MEXICO 122
11.2.3.1 Rising domestic production to drive market 122
11.3 ASIA PACIFIC 125
11.3.1 CHINA 133
11.3.1.1 World’s third–largest market for medical device production 133
11.3.2 JAPAN 136
11.3.2.1 Rising percentage of geriatric population to drive market 136
11.3.3 INDIA 138
11.3.3.1 Government initiatives to fuel demand for medical coatings 138
11.3.4 SOUTH KOREA 141
11.3.4.1 Continuous R&D activities to fuel market 141
11.3.5 AUSTRALIA 143
11.3.5.1 Rising incidence of chronic diseases drive innovation in market 143
11.3.6 REST OF ASIA PACIFIC 145
11.4 EUROPE 148
11.4.1 GERMANY 157
11.4.1.1 Innovations in medical technology to drive market 157
11.4.2 UK 159
11.4.2.1 Government initiatives for collaborative developments in
medical technology to drive market 159
11.4.3 FRANCE 162
11.4.3.1 Well–established medical device manufacturing industry
to boost market 162
11.4.4 ITALY 164
11.4.4.1 Prevalence of chronic diseases to fuel market growth 164
11.4.5 SPAIN 167
11.4.5.1 High demand for implants and catheters to boost market 167
11.4.6 RUSSIA 169
11.4.6.1 Rising demand for minimally invasive procedures to spur market 169
11.4.7 REST OF EUROPE 171
11.5 MIDDLE EAST & AFRICA 174
11.5.1 GCC COUNTRIES 183
11.5.1.1 Saudi Arabia 183
11.5.1.1.1 Government initiatives for healthcare industry
to drive market 183
11.5.1.2 UAE 186
11.5.1.2.1 Medical tourism to drive market 186
11.5.1.3 Other GCC countries 188
11.5.2 SOUTH AFRICA 191
11.5.2.1 Global investments to propel market 191
11.5.3 REST OF MIDDLE EAST & AFRICA 193
11.6 SOUTH AMERICA 196
11.6.1 BRAZIL 205
11.6.1.1 Market enhanced through local device production 205
11.6.2 ARGENTINA 207
11.6.2.1 Rising prevalence of non–communicable disease to boost market 207
11.6.3 REST OF SOUTH AMERICA 209
12 COMPETITIVE LANDSCAPE 212
12.1 OVERVIEW 212
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213
12.3 REVENUE ANALYSIS 215
12.4 MARKET SHARE ANALYSIS 216
12.5 COMPANY VALUATION AND FINANCIAL METRICS 218
12.6 BRAND/PRODUCT COMPARISON ANALYSIS 219
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221
12.7.1 STARS 221
12.7.2 EMERGING LEADERS 221
12.7.3 PERVASIVE PLAYERS 222
12.7.4 PARTICIPANTS 222
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223
12.7.5.1 Company footprint 223
12.7.5.2 Region footprint 224
12.7.5.3 Coating type footprint 224
12.7.5.4 Material footprint 225
12.7.5.5 Substrate footprint 225
12.7.5.6 Application footprint 226
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 226
12.8.1 PROGRESSIVE COMPANIES 226
12.8.2 RESPONSIVE COMPANIES 226
12.8.3 DYNAMIC COMPANIES 227
12.8.4 STARTING BLOCKS 227
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 228
12.8.5.1 Detailed list of key startups/SMEs 228
12.8.5.2 Competitive benchmarking of key startups/SMEs 229
12.9 COMPETITIVE SCENARIO 231
12.9.1 PRODUCT LAUNCHES 231
12.9.2 EXPANSIONS 232
12.9.3 DEALS 233
13 COMPANY PROFILES 235
13.1 KEY PLAYERS 235
13.1.1 HYDROMER 235
13.1.1.1 Business overview 235
13.1.1.2 Products/Solutions/Services offered 235
13.1.1.3 Recent developments 236
13.1.1.3.1 Product launches 236
13.1.1.4 MnM view 237
13.1.1.4.1 Key strengths 237
13.1.1.4.2 Strategic choices 237
13.1.1.4.3 Weaknesses and competitive threats 237
13.1.2 DSM-FIRMENICH 238
13.1.2.1 Business overview 238
13.1.2.2 Products/Solutions/Services offered 239
13.1.2.3 Recent developments 240
13.1.2.3.1 Deals 240
13.1.2.4 MnM view 240
13.1.2.4.1 Key strengths 240
13.1.2.4.2 Strategic choices 240
13.1.2.4.3 Weaknesses and competitive threats 241
13.1.3 SURMODICS, INC. 242
13.1.3.1 Business overview 242
13.1.3.2 Products/Solutions/Services offered 243
13.1.3.3 Recent developments 244
13.1.3.3.1 Product launches 244
13.1.3.4 MnM view 244
13.1.3.4.1 Key strengths 244
13.1.3.4.2 Strategic choices 244
13.1.3.4.3 Weaknesses and competitive threats 245
13.1.4 BIOCOAT INCORPORATED 246
13.1.4.1 Business overview 246
13.1.4.2 Products/Solutions/Services offered 246
13.1.4.3 Recent developments 247
13.1.4.3.1 Deals 247
13.1.4.4 Expansions 247
13.1.4.4.1 Product launches 248
13.1.4.5 MnM view 248
13.1.4.5.1 Key strengths 248
13.1.4.5.2 Strategic choices 248
13.1.4.5.3 Weaknesses and competitive threats 248
13.1.5 AST PRODUCTS INC 249
13.1.5.1 Business overview 249
13.1.5.2 Products/Solutions/Services offered 249
13.1.5.3 MnM view 250
13.1.5.3.1 Key strengths 250
13.1.5.3.2 Strategic choices 250
13.1.5.3.3 Weaknesses and competitive threats 250
13.1.6 COVALON TECHNOLOGIES 251
13.1.6.1 Business overview 251
13.1.6.2 Products/Solutions/Services offered 252
13.1.6.3 MnM view 252
13.1.6.3.1 Key strengths 252
13.1.6.3.2 Strategic choices 252
13.1.6.3.3 Weaknesses and competitive threats 252
13.1.7 FREUDENBERG MEDICAL 253
13.1.7.1 Business overview 253
13.1.7.2 Products/Solutions/Services offered 254
13.1.7.3 Recent developments 255
13.1.7.3.1 Expansions 255
13.1.7.4 MnM view 255
13.1.7.4.1 Key strengths 255
13.1.7.4.2 Strategic choices 255
13.1.7.4.3 Weaknesses and competitive threats 256
13.1.8 HARLAND MEDICAL SYSTEMS, INC. 257
13.1.8.1 Business overview 257
13.1.8.2 Products/Solutions/Services offered 257
13.1.8.3 Recent developments 258
13.1.8.3.1 Expansions 258
13.1.8.4 MnM view 259
13.1.8.4.1 Key strengths 259
13.1.8.4.2 Strategic choices 259
13.1.8.4.3 Weaknesses and competitive threats 259
13.1.9 MERIT MEDICAL SYSTEMS 260
13.1.9.1 Business overview 260
13.1.9.2 Products/Solutions/Services offered 261
13.1.9.3 MnM view 262
13.1.10 APPLIED MEDICAL COATINGS 263
13.1.10.1 Business overview 263
13.1.10.2 Products/Solutions/Services offered 263
13.1.10.3 MnM view 264
13.1.11 PPG INDUSTRIES, INC 265
13.1.11.1 Business overview 265
13.1.11.2 Products/Solutions/Services offered 266
13.1.11.3 MnM view 267
13.1.11.3.1 Key strengths 267
13.1.11.3.2 Strategic choices 267
13.1.11.3.3 Weaknesses and competitive threats 267
13.1.12 THE SHERWIN-WILLIAMS COMPANY 268
13.1.12.1 Business overview 268
13.1.12.2 Products/Solutions/Services offered 269
13.1.12.3 MnM view 269
13.1.12.3.1 Key strengths 269
13.1.12.3.2 Strategic choices 270
13.1.12.3.3 Weaknesses and competitive threats 270
13.2 OTHER PLAYERS 271
13.2.1 FORMACOAT 271
13.2.2 TUA SYSTEMS 272
13.2.3 APPLIED MEMBRANE TECHNOLOGIES 273
13.2.4 A&A COATINGS 274
13.2.5 CALICO COATINGS 275
13.2.6 COATINGS2GO 276
13.2.7 CURTISS-WRIGHT CORPORATION 277
13.2.8 ENCAPSON 278
13.2.9 ENDURA COATINGS 279
13.2.10 MEDICOAT AG 280
13.2.11 MILLER-STEPHENSON CHEMICAL COMPANY, INC. 281
13.2.12 PRECISION COATING TECHNOLOGY & MANUFACTURING INC. 282
13.2.13 SPECIALTY COATING SYSTEMS 282
14 APPENDIX 283
14.1 DISCUSSION GUIDE 283
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286
14.3 RELATED REPORTS 288
14.4 AUTHOR DETAILS 289
LIST OF TABLES
TABLE 1 LIST OF KEY SECONDARY SOURCES 30
TABLE 2 MEDICAL COATING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 51
TABLE 3 MEDICAL COATING MARKET: PORTER’S FIVE FORCES ANALYSIS 53
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP
THREE APPLICATIONS 54
TABLE 5 KEY BUYING CRITERIA FOR TOP APPLICATIONS 55
TABLE 6 EXPORT SCENARIO FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 56
TABLE 7 IMPORT SCENARIO FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 57
TABLE 8 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE)
OF KEY COUNTRIES, 2019–2023 61
TABLE 9 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTION OF KEY
COUNTRIES, 2024–2029 62
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 66
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 66
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 13 MEDICAL COATING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 68
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 73
TABLE 15 MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 79
TABLE 16 MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 80
TABLE 17 MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 80
TABLE 18 MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 80
TABLE 19 MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 86
TABLE 20 MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 86
TABLE 21 MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 87
TABLE 22 MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 87
TABLE 23 MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 93
TABLE 24 MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 94
TABLE 25 MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 94
TABLE 26 MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 94
TABLE 27 MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 100
TABLE 28 MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 100
TABLE 29 MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 101
TABLE 30 MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 101
TABLE 31 MEDICAL COATING MARKET, BY REGION, 2022–2024 (USD MILLION) 107
TABLE 32 MEDICAL COATING MARKET, BY REGION, 2025–2030 (USD MILLION) 108
TABLE 33 MEDICAL COATING MARKET, BY REGION, 2022–2024 (KILOTONS) 108
TABLE 34 MEDICAL COATING MARKET, BY REGION, 2025–2030 (KILOTONS) 108
TABLE 35 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 110
TABLE 36 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 110
TABLE 37 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (KILOTONS) 110
TABLE 38 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (KILOTONS) 110
TABLE 39 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (USD MILLION) 111
TABLE 40 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (USD MILLION) 111
TABLE 41 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (KILOTONS) 111
TABLE 42 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (KILOTONS) 112
TABLE 43 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (USD MILLION) 112
TABLE 44 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (USD MILLION) 113
TABLE 45 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (KILOTONS) 113
TABLE 46 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (KILOTONS) 114
TABLE 47 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (USD MILLION) 114
TABLE 48 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (USD MILLION) 115
TABLE 49 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (KILOTONS) 115
TABLE 50 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (KILOTONS) 115
TABLE 51 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 116
TABLE 52 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 116
TABLE 53 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 117
TABLE 54 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 117
TABLE 55 US: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 118
TABLE 56 US: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 118
TABLE 57 US: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 119
TABLE 58 US: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 119
TABLE 59 CANADA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 120
TABLE 60 CANADA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 121
TABLE 61 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 121
TABLE 62 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 122
TABLE 63 MEXICO: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 123
TABLE 64 MEXICO: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 123
TABLE 65 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 124
TABLE 66 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 124
TABLE 67 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 126
TABLE 68 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 126
TABLE 69 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 126
TABLE 70 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 127
TABLE 71 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (USD MILLION) 127
TABLE 72 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (USD MILLION) 127
TABLE 73 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (KILOTONS) 128
TABLE 74 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (KILOTONS) 128
TABLE 75 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (USD MILLION) 128
TABLE 76 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (USD MILLION) 129
TABLE 77 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 129
TABLE 78 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 130
TABLE 79 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (USD MILLION) 130
TABLE 80 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (USD MILLION) 131
TABLE 81 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (KILOTONS) 131
TABLE 82 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (KILOTONS) 131
TABLE 83 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 132
TABLE 84 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 132
TABLE 85 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 133
TABLE 86 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 133
TABLE 87 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 134
TABLE 88 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134
TABLE 89 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 135
TABLE 90 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 135
TABLE 91 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 136
TABLE 92 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137
TABLE 93 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 137
TABLE 94 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 138
TABLE 95 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 139
TABLE 96 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 139
TABLE 97 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 140
TABLE 98 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 140
TABLE 99 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 141
TABLE 100 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 142
TABLE 101 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 142
TABLE 102 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 143
TABLE 103 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 144
TABLE 104 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 144
TABLE 105 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 145
TABLE 106 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 145
TABLE 107 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 146
TABLE 108 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 146
TABLE 109 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 147
TABLE 110 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 147
TABLE 111 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 149
TABLE 112 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 149
TABLE 113 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 149
TABLE 114 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 150
TABLE 115 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (USD MILLION) 150
TABLE 116 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (USD MILLION) 150
TABLE 117 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 151
TABLE 118 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 151
TABLE 119 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 151
TABLE 120 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 152
TABLE 121 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 152
TABLE 122 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 153
TABLE 123 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 153
TABLE 124 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 154
TABLE 125 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 154
TABLE 126 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 154
TABLE 127 EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 155
TABLE 128 EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 155
TABLE 129 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 156
TABLE 130 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 156
TABLE 131 GERMANY: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 157
TABLE 132 GERMANY: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 158
TABLE 133 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 158
TABLE 134 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 159
TABLE 135 UK: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 160
TABLE 136 UK: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160
TABLE 137 UK: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 161
TABLE 138 UK: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 161
TABLE 139 FRANCE: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 162
TABLE 140 FRANCE: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 163
TABLE 141 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 163
TABLE 142 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 164
TABLE 143 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 165
TABLE 144 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 165
TABLE 145 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 166
TABLE 146 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 166
TABLE 147 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 167
TABLE 148 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 168
TABLE 149 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 168
TABLE 150 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 169
TABLE 151 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 170
TABLE 152 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 170
TABLE 153 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 171
TABLE 154 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 171
TABLE 155 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 172
TABLE 156 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 172
TABLE 157 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 173
TABLE 158 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 173
TABLE 159 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 174
TABLE 160 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 174
TABLE 161 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (KILOTONS) 175
TABLE 162 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (KILOTONS) 175
TABLE 163 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (USD MILLION) 175
TABLE 164 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (USD MILLION) 176
TABLE 165 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (KILOTONS) 176
TABLE 166 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (KILOTONS) 176
TABLE 167 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (USD MILLION) 177
TABLE 168 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (USD MILLION) 177
TABLE 169 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (KILOTONS) 178
TABLE 170 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (KILOTONS) 178
TABLE 171 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (USD MILLION) 179
TABLE 172 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (USD MILLION) 179
TABLE 173 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (KILOTONS) 180
TABLE 174 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (KILOTONS) 180
TABLE 175 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 181
TABLE 176 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 181
TABLE 177 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 182
TABLE 178 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 182
TABLE 179 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 184
TABLE 180 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 184
TABLE 181 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 185
TABLE 182 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 185
TABLE 183 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 186
TABLE 184 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 187
TABLE 185 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 187
TABLE 186 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 188
TABLE 187 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 189
TABLE 188 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 189
TABLE 189 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 190
TABLE 190 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 190
TABLE 191 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 191
TABLE 192 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 192
TABLE 193 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 192
TABLE 194 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 193
TABLE 195 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 194
TABLE 196 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 194
TABLE 197 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 195
TABLE 198 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 195
TABLE 199 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 196
TABLE 200 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 196
TABLE 201 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2022–2024 (KILOTONS) 196
TABLE 202 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY,
2025–2030 (KILOTONS) 197
TABLE 203 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (USD MILLION) 197
TABLE 204 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (USD MILLION) 197
TABLE 205 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2022–2024 (KILOTONS) 198
TABLE 206 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE,
2025–2030 (KILOTONS) 198
TABLE 207 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (USD MILLION) 199
TABLE 208 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (USD MILLION) 199
TABLE 209 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2022–2024 (KILOTONS) 200
TABLE 210 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL,
2025–2030 (KILOTONS) 200
TABLE 211 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (USD MILLION) 201
TABLE 212 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (USD MILLION) 201
TABLE 213 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2022–2024 (KILOTONS) 202
TABLE 214 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE,
2025–2030 (KILOTONS) 202
TABLE 215 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 203
TABLE 216 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 203
TABLE 217 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 204
TABLE 218 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 204
TABLE 219 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 205
TABLE 220 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 206
TABLE 221 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 206
TABLE 222 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 207
TABLE 223 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 208
TABLE 224 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 208
TABLE 225 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 209
TABLE 226 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 209
TABLE 227 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 210
TABLE 228 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 210
TABLE 229 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2022–2024 (KILOTONS) 211
TABLE 230 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION,
2025–2030 (KILOTONS) 211
TABLE 231 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL COATING MARKET BETWEEN JANUARY 2020 AND MAY 2025 213
TABLE 232 MEDICAL COATING MARKET: DEGREE OF COMPETITION 216
TABLE 233 MEDICAL COATING MARKET: REGION FOOTPRINT 224
TABLE 234 MEDICAL COATING MARKET: COATING TYPE FOOTPRINT 224
TABLE 235 MEDICAL COATING MARKET: MATERIAL FOOTPRINT 225
TABLE 236 MEDICAL COATING MARKET: SUBSTRATE FOOTPRINT 225
TABLE 237 MEDICAL COATING MARKET: APPLICATION FOOTPRINT 226
TABLE 238 MEDICAL COATING MARKET: KEY STARTUPS/SMES 228
TABLE 239 MEDICAL COATING MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/ SMES (1/2) 229
TABLE 240 MEDICAL COATING MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/ SMES (2/2) 230
TABLE 241 MEDICAL COATING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 231
TABLE 242 MEDICAL COATING MARKET: EXPANSIONS, JANUARY 2020–MAY 2025 232
TABLE 243 MEDICAL COATING MARKET: DEALS, JANUARY 2020–MAY 2025 233
TABLE 244 HYDROMER: COMPANY OVERVIEW 235
TABLE 245 HYDROMER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235
TABLE 246 HYDROMER: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 236
TABLE 247 DSM-FIRMENICH: COMPANY OVERVIEW 238
TABLE 248 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239
TABLE 249 DSM-FIRMENICH: DEALS, JANUARY 2020–MAY 2025 240
TABLE 250 SURMODICS, INC.: COMPANY OVERVIEW 242
TABLE 251 SURMODICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 243
TABLE 252 SURMODICS, INC.: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 244
TABLE 253 BIOCOAT INCORPORATED: COMPANY OVERVIEW 246
TABLE 254 BIOCOAT INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 246
TABLE 255 BIOCOAT INCORPORATED: DEALS, JANUARY 2020–MAY 2025 247
TABLE 256 BIOCOAT INCORPORATED: EXPANSIONS, JANUARY 2020–MAY 2025 247
TABLE 257 BIOCOAT INCORPORATED: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 248
TABLE 258 AST PRODUCTS INC: COMPANY OVERVIEW 249
TABLE 259 AST PRODUCTS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249
TABLE 260 COVALON TECHNOLOGIES: COMPANY OVERVIEW 251
TABLE 261 COVALON TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 262 FREUDENBERG MEDICAL: COMPANY OVERVIEW 253
TABLE 263 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254
TABLE 264 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020–MAY 2025 255
TABLE 265 HARLAND MEDICAL SYSTEMS, INC: COMPANY OVERVIEW 257
TABLE 266 HARLAND MEDICAL SYSTEMS, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257
TABLE 267 HARLAND MEDICAL SYSTEMS, INC: EXPANSIONS, JANUARY 2020–MAY 2025 258
TABLE 268 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 260
TABLE 269 MERIT MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 261
TABLE 270 APPLIED MEDICAL COATINGS: COMPANY OVERVIEW 263
TABLE 271 APPLIED MEDICAL COATINGS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 263
TABLE 272 PPG INDUSTRIES, INC: COMPANY OVERVIEW 265
TABLE 273 PPG INDUSTRIES, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 266
TABLE 274 THE SHERWIN-WILLIAMS COMPANY: COMPANY OVERVIEW 268
TABLE 275 THE SHERWIN-WILLIAMS COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
TABLE 276 FORMACOAT: COMPANY OVERVIEW 271
TABLE 277 TUA SYSTEMS: COMPANY OVERVIEW 272
TABLE 278 APPLIED MEMBRANE TECHNOLOGIES: COMPANY OVERVIEW 273
TABLE 279 A&A COATINGS: COMPANY OVERVIEW 274
TABLE 280 CALICO COATINGS: COMPANY OVERVIEW 275
TABLE 281 COATINGS2GO: COMPANY OVERVIEW 276
TABLE 282 CURTISS-WRIGHT CORPORATION: COMPANY OVERVIEW 277
TABLE 283 ENCAPSON: COMPANY OVERVIEW 278
TABLE 284 ENDURA COATINGS: COMPANY OVERVIEW 279
TABLE 285 MEDICOAT AG: COMPANY OVERVIEW 280
TABLE 286 MILLER-STEPHENSON CHEMICAL COMPANY, INC.: COMPANY OVERVIEW 281
TABLE 287 PRECISION COATING TECHNOLOGY & MANUFACTURING INC.: COMPANY OVERVIEW 282
TABLE 288 SPECIALTY COATING SYSTEMS: COMPANY OVERVIEW 282
LIST OF FIGURES
FIGURE 1 MEDICAL COATING MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 YEARS CONSIDERED 27
FIGURE 3 MEDICAL COATING MARKET: RESEARCH DESIGN 29
FIGURE 4 MEDICAL COATING MARKET: BOTTOM-UP APPROACH 33
FIGURE 5 MEDICAL COATING MARKET: TOP-DOWN APPROACH 33
FIGURE 6 MARKET SIZE ESTIMATION: MEDICAL COATING MARKET TOP-DOWN APPROACH 34
FIGURE 7 DEMAND-SIDE FORECAST PROJECTIONS 34
FIGURE 8 MEDICAL COATING MARKET: DATA TRIANGULATION 35
FIGURE 9 PASSIVE COATINGS TO DOMINATE MARKET 38
FIGURE 10 POLYMERS TO LEAD MARKET AMONG MATERIALS DURING FORECAST PERIOD 39
FIGURE 11 MEDICAL DEVICES TO HAVE HIGHEST CAGR DURING FORECAST PERIOD 39
FIGURE 12 NORTH AMERICA WAS LARGEST MARKET IN 2024 40
FIGURE 13 GROWING DEMAND FROM MEDICAL DEVICES TO DRIVE MARKET 41
FIGURE 14 ACTIVE COATING SEGMENT TO REGISTER HIGHER CAGR DURING
FORECAST PERIOD 41
FIGURE 15 POLYMERS SEGMENT TO LEAD MARKET BY VOLUME 42
FIGURE 16 POLYMERS TO BE LARGEST SUBSTRATE SEGMENT FOR MEDICAL COATINGS 42
FIGURE 17 MEDICAL DEVICES – DOMINANT APPLICATION FOR MEDICAL COATINGS 43
FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 43
FIGURE 19 MEDICAL COATING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 44
FIGURE 20 MEDICAL COATING MARKET: VALUE CHAIN ANALYSIS 49
FIGURE 21 MEDICAL COATING MARKET: ECOSYSTEM 50
FIGURE 22 MEDICAL COATING MARKET: PORTER’S FIVE FORCES ANALYSIS 52
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP
THREE APPLICATIONS 54
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 55
FIGURE 25 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD THOUSAND) 56
FIGURE 26 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY,
2020–2024 (USD THOUSAND) 57
FIGURE 27 MEDICAL COATING MARKET: TRENDS AND DISRUPTIONS IMPACTING
CUSTOMER BUSINESS 58
FIGURE 28 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 (USD/KG) 63
FIGURE 29 AVERAGE SELLING PRICE TREND, BY COATING TYPE, 2022–2024 (USD/KG) 64
FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2021–2024 (USD MILLION) 70
FIGURE 31 PATENTS APPLIED AND GRANTED, 2014–2024 71
FIGURE 32 LEGAL STATUS OF PATENTS (2014–2024) 72
FIGURE 33 MEDICAL COATING PATENTS: TOP JURISDICTIONS 72
FIGURE 34 PASSIVE COATINGS TO ACCOUNT FOR LARGER MARKET SHARE 79
FIGURE 35 POLYMERS TO ACCOUNT FOR LARGEST MARKET SHARE 85
FIGURE 36 METAL SUBSTRATES TO GROW FASTEST DURING FORECAST PERIOD 93
FIGURE 37 MEDICAL DEVICES SEGMENT TO DOMINATE MARKET 99
FIGURE 38 CHINA TO BE FASTEST–GROWING MARKET DURING FORECAST PERIOD 107
FIGURE 39 NORTH AMERICA: MEDICAL COATING MARKET SNAPSHOT 109
FIGURE 40 ASIA PACIFIC: MEDICAL COATING MARKET SNAPSHOT 125
FIGURE 41 EUROPE: MEDICAL COATING MARKET SNAPSHOT 148
FIGURE 42 REVENUE ANALYSIS OF TOP PLAYERS IN MEDICAL COATING MARKET, 2022–2024 215
FIGURE 43 MEDICAL COATING MARKET SHARE ANALYSIS, 2024 216
FIGURE 44 VALUATION OF LEADING COMPANIES IN MEDICAL COATING MARKET, 2024 218
FIGURE 45 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL COATING
MARKET, 2024 219
FIGURE 46 MEDICAL COATING MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 220
FIGURE 47 MEDICAL COATING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222
FIGURE 48 MEDICAL COATING MARKET: COMPANY FOOTPRINT 223
FIGURE 49 MEDICAL COATING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 227
FIGURE 50 DSM-FIRMENICH: COMPANY SNAPSHOT 239
FIGURE 51 SURMODICS, INC.: COMPANY SNAPSHOT 243
FIGURE 52 COVALON TECHNOLOGIES: COMPANY SNAPSHOT 251
FIGURE 53 FREUDENBERG MEDICAL: COMPANY SNAPSHOT 254
FIGURE 54 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 261
FIGURE 55 PPG INDUSTRIES: COMPANY SNAPSHOT 266
FIGURE 56 THE SHERWIN-WILLIAMS COMPANY: COMPANY SNAPSHOT 269
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11